These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution. Falchi L; Rege-Cambrin G; Fava C; Donti E; Luzi D; Giugliano E; Gubbiotti M; Schippa M; Liberati AM Cancer Genet Cytogenet; 2010 Jun; 199(2):139-42. PubMed ID: 20471518 [TBL] [Abstract][Full Text] [Related]
44. Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients. McMullan RR; McConville C; McMullin MF Ulster Med J; 2019 May; 88(2):105-110. PubMed ID: 31061559 [TBL] [Abstract][Full Text] [Related]
45. Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies. Bhattacharjee U; Jandial A; Singh C; Lekshmon KS; Mishra K; Sandal R; Nampoothiri R; Naseem S; Suri V; Jain A; Lad DP; Prakash G; Khadwal A; Malhotra P Leuk Res; 2023 Oct; 133():107367. PubMed ID: 37566974 [TBL] [Abstract][Full Text] [Related]
46. Planned pregnancy in a chronic myeloid leukemia patient in molecular remission. Pavlovsky C; Giere I; Van Thillo G Case Rep Hematol; 2012; 2012():624590. PubMed ID: 22928126 [TBL] [Abstract][Full Text] [Related]
47. Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer. Abruzzese E; Aureli S; Bondanini F; Ciccarone M; Cortis E; Di Paolo A; Fabiani C; Galimberti S; Malagola M; Malato A; Martino B; Trawinska MM; Russo D; de Fabritiis P J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407407 [TBL] [Abstract][Full Text] [Related]
48. Nilotinib induced avascular necrosis of femoral head in an adult chronic myeloid leukemia patient. Thekkudan SF; Nityanand S J Clin Orthop Trauma; 2018 Jun; 9(Suppl 2):S26-S28. PubMed ID: 29928099 [TBL] [Abstract][Full Text] [Related]
49. Successful pregnancy and delivery in a patient with chronic myeloid leukemia: a case report and review of the literature. Sheng W; Sun N Springerplus; 2016; 5(1):2055. PubMed ID: 27995032 [TBL] [Abstract][Full Text] [Related]
50. Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center. Moura AC; Delamain MT; Duarte GBO; Lorand-Metze I; Souza CA; Pagnano KBB Hematol Transfus Cell Ther; 2019; 41(2):125-128. PubMed ID: 31079659 [TBL] [Abstract][Full Text] [Related]
51. Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Abou Dalle I; Jabbour E; Short NJ; Ravandi F Curr Treat Options Oncol; 2019 Jan; 20(1):4. PubMed ID: 30675645 [TBL] [Abstract][Full Text] [Related]
52. Risks and challenges of CML management during pregnancy: Looking for a balanced decision. Chelysheva E; Turkina A Eur J Haematol; 2019 Apr; 102(4):378-379. PubMed ID: 30672625 [No Abstract] [Full Text] [Related]
53. Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors. Assunção PM; Lana TP; Delamain MT; Duarte GO; Zulli R; Lorand-Metze I; de Souza CA; de Paula EV; Barbosa Pagnano KB Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):162-166. PubMed ID: 30660512 [TBL] [Abstract][Full Text] [Related]
59. Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience. Madabhavi I; Sarkar M; Modi M; Kadakol N J Glob Oncol; 2019 Sep; 5():1-11. PubMed ID: 31584851 [TBL] [Abstract][Full Text] [Related]
60. Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience. Assi R; Kantarjian H; Keating M; Pemmaraju N; Verstovsek S; Garcia-Manero G; Ravandi F; Borthakur G; Dahl J; Jabbour E; Cortes JE Leuk Lymphoma; 2021 Apr; 62(4):909-917. PubMed ID: 33283580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]